ClearPoint Neuro Inc's Innovative Pipeline Products Under Analysis in New 2023 Update


Dublin, Dec. 28, 2023 (GLOBE NEWSWIRE) -- The "ClearPoint Neuro Inc (CLPT) - Product Pipeline Analysis, 2023 Update" company profile has been added to ResearchAndMarkets.com's offering.

ClearPoint Neuro Inc (ClearPoint) is a platform neuro company that enables therapy for neuro disorders with pinpoint accuracy. Its items incorporate the clearpoint framework a careful stage, that empowers the conveyance of treatments to treat neurological infections and issues by giving continuous X-ray direction; the smartFlow cannula an X-ray directed medication conveyance framework.

These frameworks are utilized for carrying out intrusive procedures on the mind and heart. ClearPoint collaborates with different clinical gadget organizations and scholarly establishments for the turn of events and commercialization of its item stages and center advances. It serves doctors and emergency clinics. ClearPoint is headquartered in Solana Beach, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Report Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company ClearPoint Neuro Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Key Topics Covered:

  • ClearPoint Neuro Inc Company Overview
    • ClearPoint Neuro Inc Company Snapshot
    • ClearPoint Neuro Inc Pipeline Products and Ongoing Clinical Trials Overview
    • ClearPoint Neuro Inc - Pipeline Analysis Overview
    • ClearPoint Neuro Inc - Key Facts
    • ClearPoint Neuro Inc - Major Products and Services
    • ClearPoint Neuro Inc Pipeline Products by Development Stage
    • ClearPoint Neuro Inc Ongoing Clinical Trials by Trial Status
    • ClearPoint Neuro Inc Pipeline Products Overview
  • Brain Computer Interface Navigation Software
    • Brain Computer Interface Navigation Software Product Overview
    • ClearAblate - Pancreas/Liver
  • ClearAblate - Pancreas/Liver Product Overview
    • ClearAblate - Pancreatic Cancer
    • ClearAblate - Pancreatic Cancer Product Overview
  • ClearPoint - Adjustable Drug Delivery Cannula
    • ClearPoint - Adjustable Drug Delivery Cannula Product Overview
    • ClearPoint Prism Neuro Laser Therapy System
    • ClearPoint Prism Neuro Laser Therapy System Product Overview
    • ClearPoint Prism Neuro Laser Therapy System Clinical Trial
    • ClearTrace Cardiac Intervention System
    • ClearTrace Cardiac Intervention System Product Overview
  • Implantable Neural Electrode
    • Implantable Neural Electrode Product Overview
  • Microelectric Recording (MER) System
    • Microelectric Recording (MER) System Product Overview
  • MR Safe Smart Biopsy Needle
    • MR Safe Smart Biopsy Needle Product Overview
  • MRI-Safe Myocardial Biopsy Forceps
    • MRI-Safe Myocardial Biopsy Forceps Product Overview
  • Neuro Navigation Device - Alzheimer's Disease
    • Neuro Navigation Device - Alzheimer's Disease Product Overview
    • Neuro Navigation Device - Insomnia
    • Neuro Navigation Device - Insomnia Product Overview
    • Neuro Navigation Device - Parkinson's Disease
    • Neuro Navigation Device - Parkinson's Disease Product Overview
    • Neuro Navigation Device - Severe Depression
    • Neuro Navigation Device - Severe Depression Product Overview
    • Neuro Navigation Device - Stroke Rehabilitation
    • Neuro Navigation Device - Stroke Rehabilitation Product Overview
  • Next-Generation Head Fixation Frames
    • Next-Generation Head Fixation Frames Product Overview
  • Revolution Robotic-Assisted Navigation System
    • Revolution Robotic-Assisted Navigation System Product Overview
  • ClearPoint Neuro Inc - Key Competitors
    • ClearPoint Neuro Inc - Key Employees
    • ClearPoint Neuro Inc - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Recent Developments
    • ClearPoint Neuro Inc, Recent Developments
    • Dec 11, 2023: ClearPoint Neuro Receives Additional 510(K) Clearance For ClearPoint Neuro Navigation System
    • Jun 29, 2023: Abstract From the SUS Study to Be Presented During the ESSFN Congress in Stockholm in September
    • May 16, 2023: Two Additional Clearpoint Prism Systems Installed in the U.S.
    • May 10, 2023: ClearPoint Neuro to present investigational research and showcase novel innovations at the 26th American Society of Gene & Cell Therapy Annual Meeting in Los Angeles
    • May 02, 2023: CLS Announces Enrollment Completion of Initial Phase of CLS-Sponsored Glioblastoma Laser Ablation Study With the Clearpoint Prism Neuro Laser Therapy System at Skane University Hospital
    • Apr 20, 2023: ClearPoint Neuro to showcase two novel innovations at AANS 2023: ClearPoint Maestro Brain Model and ClearPoint Prism Neuro Laser Therapy System
    • Apr 18, 2023: ClearPoint Neuro announces agreement with NE Scientific to integrate gene therapy infusion coverage tool into ClearPoint Maestro Brain Model
    • Dec 12, 2022: ClearPoint Neuro announces first patient enrolled in glioblastoma trial using ClearPoint Prism Neuro Laser Therapy System at Skane University Hospital in Sweden
    • Oct 17, 2022: Clinical Laserthermia Systems receives SEK 5.5 million order from ClearPoint Neuro
    • Sep 23, 2022: ClearPoint Neuro announces FDA clearance for ClearPoint Prism neuro laser therapy system

A selection of companies mentioned in this report includes

  • Accuray Inc
  • Varian Medical Systems Inc
  • ViewRay Inc


For more information about this company profile visit https://www.researchandmarkets.com/r/m9h4f4

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

 

Contact Data